Long‐term substitution therapy of hypogonadal men with transscrotal testosterone over 7–10 years
- 1 May 1999
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 50 (5) , 629-635
- https://doi.org/10.1046/j.1365-2265.1999.00705.x
Abstract
OBJECTIVE Testosterone (T) substitution of hypogonadal men by conventional intramuscular injection of T esters is not considered optimal because it induces unphysiologically fluctuating serum T leve...Keywords
This publication has 21 references indexed in Scilit:
- A permeation-enhanced non-scrotal testosterone transdermal system for the treatment of male hypogonadismPublished by Springer Nature ,1998
- Comparative pharmacokinetics of testosterone estersPublished by Springer Nature ,1998
- Pharmacology and clinical uses of testosteronePublished by Springer Nature ,1998
- Outcomes of Long-Term Testosterone Replacement in Older Hypogonadal Males: A Retrospective AnalysisJournal of Clinical Endocrinology & Metabolism, 1997
- Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal systemUrology, 1997
- Prostate volume in testosterone‐treated and untreated hypogonadal men in comparison to age‐matched normal controlsClinical Endocrinology, 1994
- Androgens and human benign prostatic hyperplasia (BPH)Published by Springer Nature ,1990
- Transdermal Delivery of Testosterone*Journal of Clinical Endocrinology & Metabolism, 1987
- TRANSDERMAL TESTOSTERONE SUBSTITUTION THERAPY FOR MALE HYPOGONADISMThe Lancet, 1986
- Long-term transdermal dihydrotestosterone therapy: effects on pituitary gonadal axis and plasma lipoproteinsMaturitas, 1985